Following its strong Trading Update in December 2019, Venture Life has announced its audited results for the year ending December 2019. Revenues were up 7% to £20.2m and gross margin increased to 39.6% from 38.8% in 2018. Adjusted EBITDA for the year was £3.0m and adjusted EPS was 2.18p, up 6% YoY. The results were supported by a number of product launches, partnering agreements and development and manufacturing agreements. Post year end, the company completed the acquisition of PharmaSource BV ....
